These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 35489706)

  • 1. GPR109A gene deletion ameliorates gonadectomy-induced bone loss in mice.
    Chen JR; Lazarenko OP; Blackburn ML
    Bone; 2022 Aug; 161():116422. PubMed ID: 35489706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GPR109A mediates the effects of hippuric acid on regulating osteoclastogenesis and bone resorption in mice.
    Chen JR; Zhao H; Wankhade UD; Chintapalli SV; Li C; Gai D; Shankar K; Zhan F; Lazarenko OP
    Commun Biol; 2021 Jan; 4(1):53. PubMed ID: 33420329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of bone architecture and biomechanic properties by peripheral quantitative computed tomography in rats].
    Xing XP; Xia WB; Meng XW; Zhou XY; Hu YY; Liu HC
    Zhonghua Yi Xue Za Zhi; 2003 May; 83(9):791-5. PubMed ID: 12899761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of 16-month treatment with the cathepsin K inhibitor ONO-5334 on bone markers, mineral density, strength and histomorphometry in ovariectomized cynomolgus monkeys.
    Yamada H; Ochi Y; Mori H; Nishikawa S; Hashimoto Y; Nakanishi Y; Tanaka M; Bruce M; Deacon S; Kawabata K
    Bone; 2016 May; 86():43-52. PubMed ID: 26921823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in micro-CT 3D bone parameters reflect effects of a potent cathepsin K inhibitor (SB-553484) on bone resorption and cortical bone formation in ovariectomized mice.
    Xiang A; Kanematsu M; Kumar S; Yamashita D; Kaise T; Kikkawa H; Asano S; Kinoshita M
    Bone; 2007 May; 40(5):1231-7. PubMed ID: 17347064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Jumping exercise preserves bone mineral density and mechanical properties in osteopenic ovariectomized rats even following established osteopenia.
    Okubo R; Sanada LS; Castania VA; Louzada MJ; de Paula FJ; Maffulli N; Shimano AC
    Osteoporos Int; 2017 Apr; 28(4):1461-1471. PubMed ID: 28124728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abaloparatide, a novel PTH receptor agonist, increased bone mass and strength in ovariectomized cynomolgus monkeys by increasing bone formation without increasing bone resorption.
    Doyle N; Varela A; Haile S; Guldberg R; Kostenuik PJ; Ominsky MS; Smith SY; Hattersley G
    Osteoporos Int; 2018 Mar; 29(3):685-697. PubMed ID: 29260289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative study of the bone metabolic response to dried plum supplementation and PTH treatment in adult, osteopenic ovariectomized rat.
    Smith BJ; Bu SY; Wang Y; Rendina E; Lim YF; Marlow D; Clarke SL; Cullen DM; Lucas EA
    Bone; 2014 Jan; 58():151-9. PubMed ID: 24125756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mice lacking the plasminogen activator inhibitor 1 are protected from trabecular bone loss induced by estrogen deficiency.
    Daci E; Verstuyf A; Moermans K; Bouillon R; Carmeliet G
    J Bone Miner Res; 2000 Aug; 15(8):1510-6. PubMed ID: 10934649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Turbo methanol extract inhibits bone resorption through regulation of T cell function.
    Balakrishnan B; Indap MM; Singh SP; Krishna CM; Chiplunkar SV
    Bone; 2014 Jan; 58():114-25. PubMed ID: 24140785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired bone healing pattern in mice with ovariectomy-induced osteoporosis: A drill-hole defect model.
    He YX; Zhang G; Pan XH; Liu Z; Zheng LZ; Chan CW; Lee KM; Cao YP; Li G; Wei L; Hung LK; Leung KS; Qin L
    Bone; 2011 Jun; 48(6):1388-400. PubMed ID: 21421090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abaloparatide, a novel osteoanabolic PTHrP analog, increases cortical and trabecular bone mass and architecture in orchiectomized rats by increasing bone formation without increasing bone resorption.
    Chandler H; Lanske B; Varela A; Guillot M; Boyer M; Brown J; Pierce A; Ominsky M; Mitlak B; Baron R; Kostenuik P; Hattersley G
    Bone; 2019 Mar; 120():148-155. PubMed ID: 30343166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bu-Shen-Tong-Luo decoction prevents bone loss via inhibition of bone resorption and enhancement of angiogenesis in ovariectomy-induced osteoporosis of rats.
    Yuan H; Xiao L; Min W; Yuan W; Lu S; Huang G
    J Ethnopharmacol; 2018 Jun; 220():228-238. PubMed ID: 29317302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The selective cyclooxygenase-2 inhibitor celecoxib reduces bone resorption, but not bone formation, in ovariectomized mice in vivo.
    Kasukawa Y; Miyakoshi N; Srivastava AK; Nozaka K; Maekawa S; Baylink DJ; Mohan S; Itoi E
    Tohoku J Exp Med; 2007 Mar; 211(3):275-83. PubMed ID: 17347553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abaloparatide increases bone mineral density and bone strength in ovariectomized rabbits with glucocorticoid-induced osteopenia.
    Chandler H; Brooks DJ; Hattersley G; Bouxsein ML; Lanske B
    Osteoporos Int; 2019 Aug; 30(8):1607-1616. PubMed ID: 31053927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biglycan deficiency interferes with ovariectomy-induced bone loss.
    Nielsen KL; Allen MR; Bloomfield SA; Andersen TL; Chen XD; Poulsen HS; Young MF; Heegaard AM
    J Bone Miner Res; 2003 Dec; 18(12):2152-8. PubMed ID: 14672350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Denosumab, a fully human RANKL antibody, reduced bone turnover markers and increased trabecular and cortical bone mass, density, and strength in ovariectomized cynomolgus monkeys.
    Ominsky MS; Stouch B; Schroeder J; Pyrah I; Stolina M; Smith SY; Kostenuik PJ
    Bone; 2011 Aug; 49(2):162-73. PubMed ID: 21497676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new vitamin D analog, 2MD, restores trabecular and cortical bone mass and strength in ovariectomized rats with established osteopenia.
    Ke HZ; Qi H; Crawford DT; Simmons HA; Xu G; Li M; Plum L; Clagett-Dame M; DeLuca HF; Thompson DD; Brown TA
    J Bone Miner Res; 2005 Oct; 20(10):1742-55. PubMed ID: 16160732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intermittent minodronic acid treatment with sufficient bone resorption inhibition prevents reduction in bone mass and strength in ovariectomized rats with established osteopenia comparable with daily treatment.
    Kimoto A; Tanaka M; Nozaki K; Mori M; Fukushima S; Mori H; Shiroya T; Nakamura T
    Bone; 2013 Jul; 55(1):189-97. PubMed ID: 23486179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dimethyloxalylglycine prevents bone loss in ovariectomized C57BL/6J mice through enhanced angiogenesis and osteogenesis.
    Peng J; Lai ZG; Fang ZL; Xing S; Hui K; Hao C; Jin Q; Qi Z; Shen WJ; Dong QN; Bing ZH; Fu DL
    PLoS One; 2014; 9(11):e112744. PubMed ID: 25394221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.